News & Articles

Collaboration to advance newborn genetic screening, leveraging cutting-edge genomics research and laboratory expertise to detect rare conditions early

The latest solution to enable comprehensive genomic profiling of tumors was presented at the annual meeting of the Association of Molecular Pathology

A solution for infectious disease research, delivering rapid, flexible, and scalable pathogen detection

The strategic partnership combines cutting-edge molecular profiling technology with unparalleled biospecimen and tissue profiling services

New data presented at AMP 2024 demonstrates best-in-class tissue and blood performance from both DNA and RNA

Aims to streamline clinical lab workflows with integrated tissue enrichment and nucleic acid purification solutions

CancerKB 4.0 promises comprehensive, report-ready diagnostic, prognostic, and therapeutic insights for hematological cancers, streamlining workflows with curated data from NCCN, WHO, and more

New laboratory operating system revealed at the 2024 AMP Conference in Vancouver, Canada

New guidelines for SARS-CoV-2 genomic surveillance aim to standardize NGS practices

nRichDX to unveil advanced liquid biopsy solutions at AMP 2024, showcasing high-yield sample prep innovations to enhance sensitivity in oncology diagnostics

QuantiFERON-TB Gold Plus remains crucial for the detection of latent tuberculosis infection, aiding in breaking the cycle of disease transmission

New social media channels will better serve the clinical community by making it even easier to stay up to date

Germline sequencing provides crucial insights into clonal hematopoiesis mutations with the potential to improve cancer patient outcomes and new oncology therapy development

Brand new event designed to bring together everyone working in the clinical laboratory science industry

Dr. Christian Regenbrecht discusses the power of patient-derived tumor organoids and their promising future in clinical practice

Explore the modern point-of-care ecosystem and its impact on healthcare delivery

Roche four-in-one molecular test for SARS-CoV-2, Influenza A/B viruses and RSV receives U.S. FDA Emergency Use Authorization

An introduction to the challenges and considerations for clinical labs embarking on digital transformation in healthcare

A new Oxera report has found that the NHS benefits by up to £571 million annually in bowel cancer care alone thanks to biomedical scientists, active in 95% of patient pathways

SelectScience clinical webinars can be added to HCPC and IBMS portfolios as evidence of CPD

Partnership aims to expand CE-IVD molecular assay offerings

Discover the human side of laboratory medicine with our #Lab4Life editorial feature

Discover the latest technology to supercharge your gene therapy vector analysis workflow

New device rapidly isolates blood plasma for diagnostics and precision medicine

Cologuard Plus was evaluated against an independent fecal immunochemical test, which it significantly outperformed